Status:
RECRUITING
The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis
Lead Sponsor:
Nexgen Dermatologics, Inc.
Conditions:
Dermatitis, Atopic
Pruritus
Eligibility:
All Genders
12-75 years
Phase:
NA
Brief Summary
Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceut...
Detailed Description
There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this...
Eligibility Criteria
Inclusion
- age greater than 12 years, diagnosis of atopic dermatitis for longer than 2 years, investigator's static global assessment score of either 2 or 3, and initial worst itch numerical rating scale (WI-NRS) for itch greater than 4.
Exclusion
- the use of topical or systemic corticosteroids within 28 days of entering the study, the use of any other non-emollient therapy within 28 days of entering the study,nursing, and pregnancy
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06488742
Start Date
November 1 2023
End Date
March 20 2025
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Berlin Center
Boynton Beach, Florida, United States, 33437